Contact us for free information or to start a free case review.
Neurontin, the brand name of the generic drug gabapentin, is prescribed to treat seizures commonly caused by epilepsy. The drug is also used to ease nerve pain that results from shingles.
The drug comes with a warning about side effects, including: dizziness, poor coordination or drowsiness; blurred or double vision and irregular eye movements; nausea and vomiting; or tremor.
Missing from the warning label is a mention of suicidal tendencies, which have recently been linked to the drug. Because the drug has only been approved for use in treating seizures and heat flashes from nerve diseases, the use of Neurontin to treat any other ailment could cause such unprecedented side effects, increasing the importance of only using the drug to for its approved purposes.
In 2003, Parke-Davis, the makers of Neurontin, were accused of improperly marketing the drug to treat diseases other than epilepsy, including chronic pain, migraine and bipolar disorder. A class action lawsuit was brought against the company by people claiming suicidal side effects as well as prescription use of the medication for an ailment other than epilepsy or shingles.
If the FDA has not approved a drug for a certain use, the manufacturer is not authorized to market that drug for any use other than the approved use. In the case of Parke-Davis and the Neurontin class action, people who have been prescribed the drug for uses other than epilepsy, specifically for bipolar disorder, are encouraged to talk to a lawyer about compensation from the class action.
The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were th...
Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...
The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.
The se...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.